Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01094704 · ClinicalTrials.gov registry record · Phase 1
Durability of Hypertonic Saline for Enhancing Mucociliary Clearance in Cystic Fibrosis
A Phase 1 study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT01094704 is a Phase 1 study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 16 participants.
The verdict
NCT01094704, a Phase 1 study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
Direct measurement of mucociliary and cough clearance (MCC/CC) has been used as a biomarker in cystic fibrosis (CF). Additional knowledge of the performance of this biomarker is needed to inform exploratory clinical trial design in support of programs to develop new inhaled therapies for CF. We hypothesize that MCC/CC measurements can be used to determine the durability of action of agents like hypertonic saline (HS) which increase epithelial lining fluid height.
Interventions
- DRUG sodium chloride (7%)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2009-11 |
| Est. Completion | 2010-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01094704
The ClinicalTrials.gov registry entry for NCT01094704 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which sodium chloride (7%) is the first listed.
NCT01094704 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01094704 about?
NCT01094704 is a clinical study titled "Durability of Hypertonic Saline for Enhancing Mucociliary Clearance in Cystic Fibrosis". Direct measurement of mucociliary and cough clearance (MCC/CC) has been used as a biomarker in cystic fibrosis (CF). Additional knowledge of the performance of this biomarker is needed to inform exploratory clinical trial design in support of programs to develop new inhaled therapies for CF. We hypo...
What is the current status of trial NCT01094704?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2009-11. Estimated completion is 2010-05.
What interventions are being tested in trial NCT01094704?
The interventions under investigation include: sodium chloride (7%) (DRUG).
Who is sponsoring clinical trial NCT01094704?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.